Pemphigoid, Benign Mucous Membrane: Clinical Trials

16 trials for Pemphigoid, Benign Mucous Membrane, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 3 unknown, 2 available. 6 Phase 2, 4 Phase 1, 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Terminated 1, Unknown 1, Withdrawn 1
Phase 14Completed 2, Not yet recruiting 1, Withdrawn 1
Not applicable2Unknown 1, Withdrawn 1
Phase 31Unknown 1

Follow Pemphigoid, Benign Mucous Membrane: new trials by email Literature Review of Pemphigoid, Benign Mucous Membrane trials Research Report on Pemphigoid, Benign Mucous Membrane

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Subconjunctival Humira for Boston Keratoprosthesis
Adalimumab Injection - Penetrating Keratoplasty, Multiple Graft Failure
Phase 1Not yet recruitingMassachusetts Eye and Ear Infirmary82026-10-012026-08-31
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
Plaque sampling and stool collection, periodontal examination - Pemphigoid, Benign Mucous Membrane, Gingivitis Hyperplastic
RecruitingCentre Hospitalier Universitaire de Nice452024-10-242025-03-20
Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
Rare Diseases, Aniridia
UnknownIRCCS Ospedale San Raffaele2742024-05-012024-05-14
Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
Baricitinib 2 MG [Olumiant], Methotrexate, Azathioprine - Mucous Membrane Pemphigoid, Cicatrizing Conjunctivitis
Phase 2TerminatedWashington University School of Medicine22022-02-212023-11-07
Dexamethasone Solution and Dexamethasone in Mucolox™
dexamethasone 0.5mg/5ml solution, dexamethasone 0.5mg/5ml solution in Mucolox™ - Oral Lichen Planus, Mucous Membrane Pemphigoid
Phase 2CompletedUniversity of California, San Francisco292020-12-262023-12-15
Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose Prednisolone
large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP - Benign Mucous Membrane Pemphigoid
Phase 2 / Phase 3UnknownTanta University102020-09-302021-02-09
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry - Dry Eye Syndrome, Infectious Keratoconjunctivitis
RecruitingCentre hospitalier de l'Université de Montréal (CHUM)3002020-02-012026-04-27
FARD (RaDiCo Cohort) (RaDiCo-FARD)
Inherited Epidermolysis Bullosa, Ichthyosis
RecruitingInstitut National de la Santé Et de la Recherche Médicale, France9002018-03-072026-02-12
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
EyeMate - Glaucoma, Blindness, Acquired
Not applicableWithdrawnCentre hospitalier de l'Université de Montréal (CHUM)2016-11-012018-02-05
Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis
minor salivary gland transplantation - Cicatrizing Conjunctivitis, Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
Not applicableUnknownNational Taiwan University Hospital302016-09-012019-02-15
Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
topical infliximab - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell) Syndrome
Phase 1 / Phase 2WithdrawnJames Chodosh, MD, MPH2014-11-012017-04-07
Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
cultivated oral mucosal epithelial sheet transplantation - Limbal Stem Cell Deficiency, Stevens-johnson Syndrome
AvailableSeoul National University Hospital2014-05-012016-04-20
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Riboflavin - Chemical Injuries, Unspecified Complication of Corneal Transplant
Phase 1 / Phase 2CompletedJoseph B. Ciolino, MD12012-03-012019-10-21
Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival Biopsy
papillary gum biopsies - Gingival Diseases, Gingivitis
CompletedAssistance Publique - Hôpitaux de Paris1002011-10-012020-03-03
Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
Rituximab - Ocular Cicatricial Pemphigoid
Phase 1 / Phase 2CompletedUniversity of Alabama at Birmingham32006-01-012026-05-04
Compassionate Use or Expanded Access of Dupilumab
Dupilumab - Type 2 Inflammatory Disorders
AvailableRegeneron Pharmaceuticals2026-09-01

Narrower conditions

Stevens-Johnson Syndrome (5)  ·  Pemphigus (4)  ·  Autoimmune Diseases (2)  ·  Blindness (2)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Lichen Planus, Oral (2)  ·  Limbal Stem Cell Deficiency (2)  ·  Actinic Prurigo (1)  ·  Albinism (1)  ·  Aniridia (1)  ·  Arthritis, Rheumatoid (1)  ·  Burns, Chemical (1)  ·  Chronic Urticaria (1)  ·  Conjunctivitis, Allergic (1)

Broader conditions

Conjunctival Diseases (16)  ·  Eye Diseases (16)  ·  Skin Diseases (16)  ·  Skin Diseases, Vesiculobullous (16)  ·  Skin and Connective Tissue Diseases (16)  ·  Immune System Diseases (11)  ·  Mouth Diseases (7)  ·  Stomatognathic Diseases (7)  ·  Hypersensitivity (6)  ·  Autoimmune Diseases (5)  ·  Chemically-Induced Disorders (5)  ·  Dermatitis (5)  ·  Drug Eruptions (5)  ·  Drug Hypersensitivity (5)  ·  Drug-Related Side Effects and Adverse Reactions (5)

Interventions

Solutions (2)  ·  Adalimumab (1)  ·  Azathioprine (1)  ·  Dapsone (1)  ·  Dexamethasone (1)  ·  Infliximab (1)  ·  Methotrexate (1)  ·  Mycophenolic Acid (1)  ·  Prednisolone (1)  ·  Riboflavin (1)  ·  Rituximab (1)  ·  baricitinib (1)  ·  dupilumab (1)

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM) (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  IRCCS Ospedale San Raffaele (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  James Chodosh, MD, MPH (1)  ·  Joseph B. Ciolino, MD (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  National Taiwan University Hospital (1)  ·  Regeneron Pharmaceuticals (1)  ·  Seoul National University Hospital (1)  ·  Tanta University (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, San Francisco (1)  ·  Washington University School of Medicine (1)

Countries

United States (6)  ·  Canada (2)  ·  France (2)  ·  Egypt (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Mona Harissi-Dagher, MD (2)  ·  Alessandro Villa, DDS, PhD, MPH (1)  ·  Claes H Dohlman, MD, PhD (1)  ·  Craig A Elmets (1)  ·  Hsiao-Sang Chu, MD, MS (1)  ·  James Chodosh, MD, MPH (1)  ·  Joseph Ciolino, MD (1)  ·  Marie-Claude Robert, MD, M.Sc (1)  ·  Mee Kum Kim, MD, PhD (1)  ·  Thomas Dohlman, MD (1)

Results publications

PMID 34535102, PMID 37549933